{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:40:28Z","timestamp":1782952828624,"version":"3.54.5"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:label\/>\n                  <jats:p>We aimed to determine the role of serum cytokine expression in invasive aspergillosis (IA) diagnosis and outcome prediction in hematologic patients. In this multicenter study, serum cytokines (IL6, IL10, INF-gamma, IL12, IL4, TNF-alpha, IL17, and IL23) were prospectively recruited from all consecutive patients with hematologic malignances at IA diagnosis and compared to control patients matched by center, age, baseline disease, and therapeutic regimen. We included 36 patients with IA and 36 controls. Serum levels of IL6 and IL10 cytokines on day 0 were significantly increased in patients with IA when compared to controls (P\u00a0=\u00a00.001 and P\u00a0=\u00a00.025, respectively), even in those who were neutropenic. No differences were observed for the other cytokines. IL6 and IL10 predicted IA with an area under the ROC curve of 0.74 (95% CI 0.62\u20130.86) and 0.64 (95% CI 0.51\u20130.77), respectively. The best cutoff point in predicting IA was 20.85 pg\/ml for IL6 (sensitivity 72.2%; specificity 77.8%; PPV 76.5% and NPV 73.7%), and 0.045 pg\/ml for IL10 (sensitivity 62.9%; specificity 63.9%; PPV 62.9% and NPV 63.9%). IL6 levels were associated with increased mortality, with the best cutoff value being 65.59 pg\/ml in mortality prediction. In conclusion, in addition to current tests in place, IL6 and IL10 levels\u2014as measured in plasma\u2014may help clinicians diagnose IA. High levels of IL6 at IA diagnosis are related with worse outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Lay summary<\/jats:title>\n                  <jats:p>We evaluated the role of serum cytokine expression in invasive aspergillosis (IA) diagnosis and outcome. Serum levels of IL6 and IL10 are increased in patients with IA compared to controls, and IL6 levels are associated with mortality.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mmy\/myac038","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T14:24:18Z","timestamp":1654179858000},"source":"Crossref","is-referenced-by-count":5,"title":["Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis"],"prefix":"10.1093","volume":"60","author":[{"given":"Pedro","family":"Puerta-Alcalde","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Hospital Clinic de Barcelona , Barcelona 08036, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Ruiz-Camps","sequence":"additional","affiliation":[{"name":"Hospital Universitari de la Vall d'Hebron, Universitat Aunt\u00f2noma de Barcelona , Barcelona 08193, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Gudiol","sequence":"additional","affiliation":[{"name":"Hospital Universitari de Bellvitge, Institut d\u00b4Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL), Universitat de Barcelona, L'Hospitalet de Llobregat , 08007, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III , Madrid 41092, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Salavert","sequence":"additional","affiliation":[{"name":"Hospital Universitari La Fe , Valencia 46026, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Barba","sequence":"additional","affiliation":[{"name":"Hospital Universitari de la Vall d'Hebron, Universitat Aunt\u00f2noma de Barcelona , Barcelona 08193, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Morandeira","sequence":"additional","affiliation":[{"name":"Hospital Universitari de Bellvitge, Institut d\u00b4Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL), Universitat de Barcelona, L'Hospitalet de Llobregat , 08007, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III , Madrid 41092, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro","family":"Jarque","sequence":"additional","affiliation":[{"name":"Hospital Universitari La Fe , Valencia 46026, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Cuervo","sequence":"additional","affiliation":[{"name":"Hospital Universitari de Bellvitge, Institut d\u00b4Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL), Universitat de Barcelona, L'Hospitalet de Llobregat , 08007, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III , Madrid 41092, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Ayats","sequence":"additional","affiliation":[{"name":"Hospital Universitari de Bellvitge, Institut d\u00b4Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL), Universitat de Barcelona, L'Hospitalet de Llobregat , 08007, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III , Madrid 41092, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Carratal\u00e0","sequence":"additional","affiliation":[{"name":"Hospital Universitari de Bellvitge, Institut d\u00b4Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL), Universitat de Barcelona, L'Hospitalet de Llobregat , 08007, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III , Madrid 41092, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8915-0683","authenticated-orcid":false,"given":"Carolina","family":"Garcia-Vidal","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Clinic de Barcelona , Barcelona 08036, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"issue":"8","key":"2022072312384618800_bib1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the transplant- associated infection surveillance network (TRANSNET) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis."},{"issue":"4","key":"2022072312384618800_bib2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B\u2013Based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2022072312384618800_bib3","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1128\/AAC.00673-10","article-title":"The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1\u21923)-\u03b2-D-glucan, and consequences of delayed antifungal therapy","volume":"54","author":"Hope","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2022072312384618800_bib4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/QCO.0b013e32835fb920","article-title":"Pathogenesis of invasive fungal infections","volume":"26","author":"Garcia-Vidal","year":"2013","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"2022072312384618800_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.eimc.2011.09.011","article-title":"Patogenia de la infecci\u00f3n f\u00fangica invasora","volume":"30","author":"Garcia-Vidal","year":"2012","journal-title":"Enfermedades Infecciosas Y Microbiologia Clinica"},{"issue":"12","key":"2022072312384618800_bib6","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer\/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC\/MSG) C","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Inf Dis."},{"key":"2022072312384618800_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.critrevonc.2015.10.005","article-title":"Adoptive transfer of Aspergillus-specific t cells as a novel anti-fungal therapy for hematopoietic stem cell transplant recipients: progress and challenges","volume":"98","author":"Papadopoulou","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"2022072312384618800_bib8","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1002\/jmv.26654","article-title":"Defining IL-6 levels in healthy individuals: A meta-analysis","volume":"93","author":"Said","year":"2021","journal-title":"J. Med. Virol"},{"issue":"8","key":"2022072312384618800_bib9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.eimc.2018.03.018","article-title":"Executive summary of clinical practice guideline for the management of invasive diseases caused by aspergillus: 2018 update by the GEMICOMED-SEIMC\/REIPI","volume":"37","author":"Garcia-Vidal","year":"2019","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"11","key":"2022072312384618800_bib10","doi-asserted-by":"crossref","first-page":"O939","DOI":"10.1111\/1469-0691.12650","article-title":"Environmental variables associated with an increased risk of invasive aspergillosis","volume":"20","author":"Garcia-Vidal","year":"2014","journal-title":"Clinical Microbiology and Infection."},{"issue":"4","key":"2022072312384618800_bib11","doi-asserted-by":"crossref","first-page":"e18403","DOI":"10.1371\/journal.pone.0018403","article-title":"Influence of polymorphisms in innate immunity genes on susceptibility to invasive aspergillosis after stem cell transplantation","volume":"6","author":"de Boer","year":"2011","journal-title":"Plos One"},{"issue":"3","key":"2022072312384618800_bib12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/IAI.01359-15","article-title":"Polymorphisms in host immunity-modulating genes and risk of invasive aspergillosis: results from the aspbiomics consortium","volume":"84","author":"Lupia\u00f1ez","year":"2016","journal-title":"Infect Immun"},{"issue":"12","key":"2022072312384618800_bib13","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/myc.12679","article-title":"Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis","volume":"60","author":"Heldt","year":"2017","journal-title":"Mycoses"},{"key":"2022072312384618800_bib14","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.3389\/fmicb.2017.02362","article-title":"Evaluation of bronchoalveolar lavage fluid cytokines as biomarkers for invasive pulmonary aspergillosis in at-risk patients","volume":"8","author":"Gon\u00e7alves","year":"2017","journal-title":"Front Microbiol"},{"issue":"7","key":"2022072312384618800_bib15","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/jim-2021-001857","article-title":"Diagnosis values of IL-6 and IL-8 levels in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in chronic obstructive pulmonary disease","volume":"69","author":"Liu","year":"2021","journal-title":"Jour of Invest Med."}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myac038\/43933426\/myac038.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/60\/7\/myac038\/45052096\/myac038.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/60\/7\/myac038\/45052096\/myac038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T12:39:49Z","timestamp":1658579989000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myac038\/6598867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,23]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myac038","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7]]},"published":{"date-parts":[[2022,6,2]]},"article-number":"myac038"}}